Illumina capture sequencing in routine AML patients
收藏NIAID Data Ecosystem2026-03-12 收录
官方服务：
资源简介：
185 patients aged 18 to 60 years old diagnosed with de novo or secondary AML. This population was composed of 114 FLT3-ITD positive patients and 71 FLT3-ITD negative patients by fragment analysis.Peripheral blood or bone marrow samples from AML patients were screened with our standard NGS routine with a capture method (SSQXT Agilent) and sequenced with Illumina technology.
创建时间：
2021-07-01
